Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Methamphetamine Dependence
NCT00069251Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in methamphetamine use disorder (MUD), sponsored by National Institute on Drug Abuse. Started Jul 2003; status: completed.
02
Drugs
bupropion
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00069251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069251.